Randomized Trial of Time-Limited Interruptions of Protease Inhibitor-Based Antiretroviral Therapy (ART) vs. Continuous Therapy for HIV-1 Infection

• Cynthia Firnhaber ,

  Contributed equally to this work with: Cynthia Firnhaber, Livio Azzoni

  Affiliation Clinical HIV Research Unit, Faculty of Health Sciences, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Livio Azzoni ,

  Contributed equally to this work with: Cynthia Firnhaber, Livio Azzoni

  Affiliation The Wistar Institute, Philadelphia, Pennsylvania, United States of America

  ⨯
• Andrea S. Foulkes,

  Affiliation Division of Biostatistics, University of Massachusetts, Amherst, Massachusetts, United States of America

  ⨯
• Robert Gross,

  Affiliation Departments of Medicine (Infectious Diseases) and Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯
• Xiangfan Yin,

  Affiliation The Wistar Institute, Philadelphia, Pennsylvania, United States of America

  ⨯
• Desiree Van Amsterdam,

  Affiliation Clinical HIV Research Unit, Faculty of Health Sciences, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Doreen Schulze,

  Affiliation Clinical HIV Research Unit, Faculty of Health Sciences, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Deborah K. Glencross,

  Affiliation Department of Molecular Medicine and Haematology, University of the Witwatersrand and the National Health Laboratory Services, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Wendy Stevens,

  Affiliation Department of Molecular Medicine and Haematology, University of the Witwatersrand and the National Health Laboratory Services, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Gillian Hunt,

  Affiliation National Institute for Communicable Diseases, Johannesburg, South Africa

  ⨯
• Lynn Morris,

  Affiliation National Institute for Communicable Diseases, Johannesburg, South Africa

  ⨯
• Lawrence Fox,

  Affiliation Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, Maryland, United States of America

  ⨯
• Ian Sanne ,

  ¶These authors also contributed equally to this work.

  Affiliation Clinical HIV Research Unit, Faculty of Health Sciences, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Luis J. Montaner

  * E-mail: montaner@wistar.org

  ¶These authors also contributed equally to this work.

  Affiliation The Wistar Institute, Philadelphia, Pennsylvania, United States of America

  ⨯